Literature DB >> 12500222

Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock.

Jose Iglesias1, Paul E Marik, Jerrold S Levine.   

Abstract

BACKGROUND: Acute renal failure (ARF), a common and serious complication in patients with septic shock, has high mortality. Recent data suggest that proinflammatory cytokines may contribute to sepsis-associated ARF.
METHODS: To examine the role of proinflammatory cytokines, we evaluated 537 patients enrolled in the placebo arm of the Norasept II study, of whom 112 patients (20%) developed ARF.
RESULTS: By univariate analysis, the following factors were significantly associated with the development of ARF: male sex, younger age, increased heart rate, higher Acute Physiology and Chronic Health Evaluation II score, oliguria, increased blood urea nitrogen level, increased serum creatinine (Scr) level, decreased arterial pH, and increased serum potassium level. Although there were no statistically significant differences in serum levels of tumor necrosis factor-alpha (TNF-alpha) or interleukin-6 between patients with and without ARF, elevated serum levels of the two soluble TNF-alpha receptors (S-TNF-RI and S-TNF-RII) were strongly associated with the development of ARF (S-TNF-RI, 25 +/- 16 versus 18 +/- 13 ng/mL; P = 0.00006; S-TNF-RII, 25 +/- 21 versus 18 +/- 17 ng/mL; P = 0.0007). Using forward stepwise regression analysis, elevated S-TNF-R level remained an independent predictor for ARF, even when we limited our analysis to patients with Scr levels of 1.4 mg/dL or less (< or =124 micromol/L) at study entry, suggesting that decreased renal clearance of S-TNF-R alone cannot account for this association. Elevated S-TNF-R level also was an independent predictor of mortality among patients developing ARF.
CONCLUSION: S-TNF-R level is an independent predictor for the development of ARF and mortality. We speculate that elevated S-TNF-R levels may reflect a more intense inflammatory response. Copyright 2003 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12500222     DOI: 10.1053/ajkd.2003.50024

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  22 in total

1.  Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS.

Authors:  Roxanne Cofiell; Anjli Kukreja; Krystin Bedard; Yan Yan; Angela P Mickle; Masayo Ogawa; Camille L Bedrosian; Susan J Faas
Journal:  Blood       Date:  2015-04-01       Impact factor: 22.113

2.  Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy.

Authors:  Raghavan Murugan; Xiaoyan Wen; Nilesh Shah; Minjae Lee; Lan Kong; Francis Pike; Christopher Keener; Mark Unruh; Kevin Finkel; Anitha Vijayan; Paul M Palevsky; Emil Paganini; Melinda Carter; Michele Elder; John A Kellum
Journal:  Nephrol Dial Transplant       Date:  2014-03-11       Impact factor: 5.992

3.  The course of type 1 hepato-renal syndrome post liver transplantation.

Authors:  Paul E Marik; Kelly Wood; Thomas E Starzl
Journal:  Nephrol Dial Transplant       Date:  2005-10-25       Impact factor: 5.992

4.  A role for cGMP in inducible nitric-oxide synthase (iNOS)-induced tumor necrosis factor (TNF) α-converting enzyme (TACE/ADAM17) activation, translocation, and TNF receptor 1 (TNFR1) shedding in hepatocytes.

Authors:  R Savanh Chanthaphavong; Patricia A Loughran; Tiffany Y S Lee; Melanie J Scott; Timothy R Billiar
Journal:  J Biol Chem       Date:  2012-08-16       Impact factor: 5.157

Review 5.  Biomarkers of acute kidney injury.

Authors:  Charles L Edelstein
Journal:  Adv Chronic Kidney Dis       Date:  2008-07       Impact factor: 3.620

6.  Association of Soluble TNFR-1 Concentrations with Long-Term Decline in Kidney Function: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Pavan K Bhatraju; Leila R Zelnick; Michael Shlipak; Ronit Katz; Bryan Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2018-10-04       Impact factor: 10.121

7.  A biomarker panel to discriminate between systemic inflammatory response syndrome and sepsis and sepsis severity.

Authors:  Chamindie Punyadeera; E Marion Schneider; Dave Schaffer; Hsin-Yun Hsu; Thomas O Joos; Fabian Kriebel; Manfred Weiss; Wim Fj Verhaegh
Journal:  J Emerg Trauma Shock       Date:  2010-01

8.  Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury.

Authors:  Kathleen D Liu; David V Glidden; Mark D Eisner; Polly E Parsons; Lorraine B Ware; Arthur Wheeler; Anna Korpak; B Taylor Thompson; Glenn M Chertow; Michael A Matthay
Journal:  Crit Care Med       Date:  2007-12       Impact factor: 7.598

9.  Using best subset regression to identify clinical characteristics and biomarkers associated with sepsis-associated acute kidney injury.

Authors:  Y Diana Kwong; Kala M Mehta; Christine Miaskowski; Hanjing Zhuo; Kimberly Yee; Alejandra Jauregui; Serena Ke; Thomas Deiss; Jason Abbott; Kirsten N Kangelaris; Pratik Sinha; Carolyn Hendrickson; Antonio Gomez; Aleksandra Leligdowicz; Michael A Matthay; Carolyn S Calfee; Kathleen D Liu
Journal:  Am J Physiol Renal Physiol       Date:  2020-10-12

10.  Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population.

Authors:  Dinna N Cruz; Massimo de Cal; Francesco Garzotto; Mark A Perazella; Paolo Lentini; Valentina Corradi; Pasquale Piccinni; Claudio Ronco
Journal:  Intensive Care Med       Date:  2009-12-03       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.